K. Hoogtanders

672 total citations
15 papers, 532 citations indexed

About

K. Hoogtanders is a scholar working on Transplantation, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, K. Hoogtanders has authored 15 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Transplantation, 8 papers in Pediatrics, Perinatology and Child Health and 4 papers in Epidemiology. Recurrent topics in K. Hoogtanders's work include Renal Transplantation Outcomes and Treatments (10 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Metabolism and Genetic Disorders (3 papers). K. Hoogtanders is often cited by papers focused on Renal Transplantation Outcomes and Treatments (10 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Metabolism and Genetic Disorders (3 papers). K. Hoogtanders collaborates with scholars based in Netherlands and China. K. Hoogtanders's co-authors include Leo Stolk, J. van der Heijden, Maarten H. L. Christiaans, M. Christiaans, Peter M. Edelbroek, J. P. van Hooff, Cees Neef, Johannes van Hooff, G.J. de Jong and Rob E. Aarnoutse and has published in prestigious journals such as Transplantation, Clinica Chimica Acta and Journal of Pharmaceutical and Biomedical Analysis.

In The Last Decade

K. Hoogtanders

15 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Hoogtanders Netherlands 11 298 184 168 147 104 15 532
J. van der Heijden Netherlands 6 242 0.8× 125 0.7× 137 0.8× 122 0.8× 75 0.7× 9 408
Herman Veenhof Netherlands 12 415 1.4× 170 0.9× 160 1.0× 109 0.7× 156 1.5× 14 618
Lisa C. Martial Netherlands 10 113 0.4× 81 0.4× 81 0.5× 61 0.4× 36 0.3× 13 325
René Vos Netherlands 11 124 0.4× 51 0.3× 82 0.5× 41 0.3× 83 0.8× 16 334
Sofie Velghe Belgium 7 280 0.9× 18 0.1× 78 0.5× 59 0.4× 82 0.8× 8 412
Lisa Delahaye Belgium 8 213 0.7× 24 0.1× 54 0.3× 42 0.3× 59 0.6× 13 332
M. Christiaans Netherlands 4 98 0.3× 84 0.5× 57 0.3× 58 0.4× 33 0.3× 5 199
Meagan J. Bemer United States 10 28 0.1× 157 0.9× 68 0.4× 55 0.4× 196 1.9× 16 363
C Vidal Germany 11 19 0.1× 226 1.2× 116 0.7× 84 0.6× 13 0.1× 16 463
Ian S Westley Australia 12 35 0.1× 521 2.8× 88 0.5× 378 2.6× 15 0.1× 23 759

Countries citing papers authored by K. Hoogtanders

Since Specialization
Citations

This map shows the geographic impact of K. Hoogtanders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Hoogtanders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Hoogtanders more than expected).

Fields of papers citing papers by K. Hoogtanders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Hoogtanders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Hoogtanders. The network helps show where K. Hoogtanders may publish in the future.

Co-authorship network of co-authors of K. Hoogtanders

This figure shows the co-authorship network connecting the top 25 collaborators of K. Hoogtanders. A scholar is included among the top collaborators of K. Hoogtanders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Hoogtanders. K. Hoogtanders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wijma, Rixt A., K. Hoogtanders, Sander Croes, Johan W. Mouton, & Roger J. M. Brüggemann. (2019). Development and validation of a fast and sensitive UHPLC-DAD assay for the quantification of nitrofurantoin in plasma and urine. Journal of Pharmaceutical and Biomedical Analysis. 174. 161–167. 14 indexed citations
2.
Martial, Lisa C., K. Hoogtanders, Michiel F. Schreuder, et al.. (2017). Dried Blood Spot Sampling for Tacrolimus and Mycophenolic Acid in Children: Analytical and Clinical Validation. Therapeutic Drug Monitoring. 39(4). 412–421. 42 indexed citations
3.
Donders, A. Rogier T., et al.. (2015). Limited sampling strategy for prolonged-release tacrolimus in renal transplant patients by use of the dried blood spot technique. European Journal of Clinical Pharmacology. 71(7). 811–816. 25 indexed citations
4.
Colbers, Angela, et al.. (2015). Pharmacokinetic Drug–drug Interaction Study between Raltegravir and Citalopram. Antiviral Therapy. 21(2). 143–152. 6 indexed citations
5.
Aarnoutse, Rob E., et al.. (2014). Delayed trough level measurement with the use of prolonged-release tacrolimus. Transplant International. 28(3). 314–318. 6 indexed citations
6.
Aarnoutse, Rob E., et al.. (2012). Effect of Mild Diarrhea on Tacrolimus Exposure. Transplantation. 94(7). 763–767. 13 indexed citations
7.
Heijden, J. van der, K. Hoogtanders, Maarten H. L. Christiaans, et al.. (2008). Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography–mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 50(4). 664–670. 90 indexed citations
8.
Cheung, Chi Yuen, J. van der Heijden, K. Hoogtanders, et al.. (2008). DRIED BLOOD SPOT MEASUREMENT: APPLICATION IN TACROLIMUS MONITORING USING LIMITED SAMPLING STRATEGY AND ABBREVIATED AUC ESTIMATION. Transplantation. 86(2S). 539–539. 30 indexed citations
9.
Wijnen, Petal A., Chi Yuen Cheung, K. Hoogtanders, et al.. (2007). Genotyping with a dried blood spot method: A useful technique for application in pharmacogenetics. Clinica Chimica Acta. 388(1-2). 189–191. 16 indexed citations
10.
Cheung, Chi Yuen, J. van der Heijden, K. Hoogtanders, et al.. (2007). Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation. Transplant International. 0(0). 4171741937–???. 64 indexed citations
11.
Hoogtanders, K., et al.. (2007). Dried Blood Spot Measurement of Tacrolimus Is Promising for Patient Monitoring. Transplantation. 83(2). 237–238. 50 indexed citations
12.
Hoogtanders, K., J. van der Heijden, M. Christiaans, et al.. (2006). Therapeutic drug monitoring of tacrolimus with the dried blood spot method. Journal of Pharmaceutical and Biomedical Analysis. 44(3). 658–664. 154 indexed citations
13.
Stolk, Leo & K. Hoogtanders. (1999). Detection of laxative abuse by urine analysis with HPLC and diode array detection.. Pharmacy World & Science. 21(1). 40–43. 9 indexed citations
14.
Hoogtanders, K., et al.. (1997). 164 A SEMI-AUTOMATED SENSITIVE HPLC METHOD FOR DETERMINATION OF M-CHLOROPHENYLPIPERAZINE IN PLASMA. Therapeutic Drug Monitoring. 19(5). 588–588. 1 indexed citations
15.
Beysens, A. J. M. M., et al.. (1994). Determination of tacrolimus (FK 506) in whole blood using liquid chromatography and fluorescence detection. Chromatographia. 39(7-8). 490–496. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026